Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
Bulletin Du Cancer
|
October 1, 1996
[Treatment of aggressive non Hodgkin's lymphoma: the experience of a general hospital]
F M Laurencet, G B Zulian, P Y Dietrich, et al.
The Journal of Investigative Dermatology
|
December 24, 1997
Transformed and nontransformed human T lymphocytes migrate to skin in a chimeric human skin/SCID mouse model
N Rosenblatt-Velin, J F Arrighi, P Y Dietrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2008
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers
R Stupp, A F Hottinger, M J van den Bent, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
October 1, 1995
Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancer
E Angevin, D Valteau-Couanet, F Farace, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 1, 2014
Aggressiveness of cancer treatment in patients hospitalized in a supportive care unit
C Luthy, A Pugliesi, E Rapiti, et al.
International Journal of Cancer
|
July 9, 1993
Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma
F Farace, E Angevin, B Escudier, et al.
Bulletin Du Cancer
|
January 1, 1992
[Secondary solid tumors after Hodgkin's disease radiotherapy; experience at the Gustave Roussy Institute]
J M Cosset, M Henry-Amar, P Y Dietrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2000
The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells
P R Walker, T Calzascia, V Schnuriger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1995
Lymphoma of uncertain phenotype
G B Zulian, P Y Dietrich, B Conne, et al.
Revue Medicale Suisse
|
September 30, 2011
[Anticancer drugs under pressure]
A Ben Aïssa, A-C George, F Z El M'Rabet, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
Bulletin Du Cancer
|
October 1, 1996
[Treatment of aggressive non Hodgkin's lymphoma: the experience of a general hospital]
F M Laurencet, G B Zulian, P Y Dietrich, et al.
The Journal of Investigative Dermatology
|
December 24, 1997
Transformed and nontransformed human T lymphocytes migrate to skin in a chimeric human skin/SCID mouse model
N Rosenblatt-Velin, J F Arrighi, P Y Dietrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2008
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers
R Stupp, A F Hottinger, M J van den Bent, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
October 1, 1995
Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancer
E Angevin, D Valteau-Couanet, F Farace, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 1, 2014
Aggressiveness of cancer treatment in patients hospitalized in a supportive care unit
C Luthy, A Pugliesi, E Rapiti, et al.
International Journal of Cancer
|
July 9, 1993
Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma
F Farace, E Angevin, B Escudier, et al.
Bulletin Du Cancer
|
January 1, 1992
[Secondary solid tumors after Hodgkin's disease radiotherapy; experience at the Gustave Roussy Institute]
J M Cosset, M Henry-Amar, P Y Dietrich, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2000
The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells
P R Walker, T Calzascia, V Schnuriger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1995
Lymphoma of uncertain phenotype
G B Zulian, P Y Dietrich, B Conne, et al.
Revue Medicale Suisse
|
September 30, 2011
[Anticancer drugs under pressure]
A Ben Aïssa, A-C George, F Z El M'Rabet, et al.
Page
of 10